Feasibility of a low-fat/high-fiber diet intervention with soy supplementation in prostate cancer patients after prostatectomy

European Journal of Clinical Nutrition

Volumn 62, Issue 4, 2008, Pages 526-536

  Li, Z ^a,b   Aronson, W J ^b,c   Arteaga, J R ^a   Hong, K ^a   Thames, G ^a   Henning, S M ^a   Liu, W ^c   Elashoff, R ^c   Ashley, J M ^d   Heber, D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF NEVADA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOFLAVONE; SOMATOMEDIN C; SOYBEAN PROTEIN; BIOLOGICAL MARKER; ISOFLAVONE DERIVATIVE;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVOR; CELL GROWTH; CELL STRAIN LNCAP; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DIET SUPPLEMENTATION; EX VIVO STUDY; FAT INTAKE; HIGH FIBER DIET; HUMAN; LOW FAT DIET; MALE; NUTRITIONAL ASSESSMENT; PATIENT COMPLIANCE; PROSTATE CANCER; PROSTATECTOMY; RECURRENCE RISK; UNITED STATES; URINARY EXCRETION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIET THERAPY; DIETARY FIBER; DOSE RESPONSE; METABOLISM; MIDDLE AGED; PROSTATE TUMOR; RANDOMIZED CONTROLLED TRIAL; TUMOR RECURRENCE; URINE;

ADULT; AGED; BIOLOGICAL MARKERS; DIET, FAT-RESTRICTED; DIETARY FATS; DIETARY FIBER; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INSULIN-LIKE GROWTH FACTOR I; ISOFLAVONES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATECTOMY; PROSTATIC NEOPLASMS; SOYBEAN PROTEINS;

EID: 46149098734     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1602743     Document Type: Article

References (32)

1. Adlercreutz H, Honjo H, Higashi A, Fotsis T, Hamalainen E, Hasegawa T et al. (1991). Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am J Clin Nutr 54, 1093-1100.
2. Boyle P, Levi F, Lucchini F, La VC, Kevi R, Lucchuni F (1993). Trends in diet-related cancers in Japan: A conundrum? Lancet 342, 752.
3. Chan JM, Stampfer W, Giovannucci E, Gann PH, Ma J, Wilkinson P et al. (1998). Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279, 563-566.
4. Cohen P. Peehl DM, Baker B, Liu F, Hintz RL, Rosenfeld RG (1994). Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia. J Clin Endocrinol Metab 79, 1410-1415.
5. Collett-Solberg PF, Cohen P (1996). The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action. Endocrinol Metab Clin North Am 25, 591-614.
6. Elmer PJ, Grimm Jr R, Laing B, Grandits G, Svendsen K, Van HN et al. (1995). Lifestyle intervention: Results of the Treatment of Mild Hypertension Study (TOMHS). Prev Med 24, 378-388.
7. Ferry Jr RJ, Katz LE, Grimberg A, Cohen P, Weinzimer SA (1999). Cellular actions of insulin-like growth factor binding proteins. Horm Metab Res 31, 192-202.
8. Hebert JR, Hurley TG, Olendzki BC, Teas J, Ma Y, Hampl JS (1998). Nutritional and socioeconomic factors in relation to prostate cancer mortality: A cross-national study. J Natl Cancer Inst 90, 1637-1647.
9. Huang MH, Harrison GG, Mohamed MM, Gombein JA, Henning SM, Go VL et al. (2000). Assessing the accuracy of a food frequency questionnaire for estimating usual intake of phytoestrogens. Nutr Cancer 37 145-154.
10. Jeffery RW, Bjornson-Benson WM, Rosenthal BS, Lindquist RA, Kurth CL, Johnson SL (1984). Correlates of weight loss and its maintenance over two years of follow-up among middle-aged men. Prev Med 13, 155-168.
11. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A et al. (2005). Cancer statistics, 2005. CA Cancer J Clin 55, 10-30.
12. Kaplan PJ, Mohan S, Cohen P, Foster BA, Greenberg NM (1999). The insulin-like growth factor axis and prostate cancer: Lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model. Cancer Res 59, 2203-2209.
13. Khuntia D, Reddy CA, Mahadevan A, Klein EA, Kupelian PA (2004). Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1-T3 prostate carcinoma in the prostate-specific antigen era: What should we expect? Cancer 100, 1283-1292.
14. Kondo Y, Homma. Y, Aso Y, Kakizoe T (1994). Promotional effect of two-generation exposure to a high-fat diet on prostate carcinogenesis in ACI/Seg rats. Cancer Res 54, 6129-6132.
15. Lanza E, Schatzkin A, Daston C, Corle D, Freedman L, Ballard-Barbash R et al. (2001). Implementation of a 4-y, high-fiber, high-fruit-and-vegetable, low-fat dietary intervention: Results of dietary changes in the Polyp Prevention Trial. Am J Clin Nutr 74, 387-401.
16. Mills PK, Beeson WL, Phillips RL, Fraser GE (1989). Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer 64, 598-604.
17. Ngo TH, Barnard RJ, Anton T, Tran C, Elashoff D, Heber D et al. (2004). Effect of isocaloric low-fat diet on prostate cancer xenograft progression to androgen independence. Cancer Res 64, 1252-1254.
18. Ngo TH, Barnard RJ, Tymchuk CN, Cohen P, Aronson WJ (2002). Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro (United States). Cancer Causes Control 13, 929-935.
19. Ornish D, Weidner G, Fair WR, Marlin R, Pettengill EB, Raisin CJ et al. (2005). Intensive lifestyle changes may affect the progression of prostate cancer. J Urol 174, 1065-1069.
20. Peterson G, Barnes S (1993). Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation. Prostate 22, 335-345.
21. Rose DP, Connolly JM (1992). Dietary fat, fatty acids and prostate cancer. Lipids 27, 798-803.
22. Severson RK, Nomura AM, Grove JS, Stemmermann GN (1989). A prospective analysis of physical activity and cancer. Am J Epidemiol 130 522-529.
23. Shike M, Latkany L, Riedel E, Fleisher M, Schatzkin A, Lanza E et al. (2002). Lack of effect of a low-fat, high-fruit, -vegetable, and -fiber diet on serum prostate-specific antigen of men without prostate cancer: Results from a randomized trial. J Clin Oncol 20, 3592-3598.
24. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM (1991). Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 63, 963-966.
25. Stattin P, Bylund A, Rinaldi S, Biessy C, Dechaud H, Stenman UH et al. (2000). Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: A prospective study. J Natl Cancer Inst 92, 1910-1917.
26. Trapasso JG, deKernion JB, Smith RB, Dorey F (1994). The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy. J Urol 152, 1821-1825.
27. Tymchuk CN, Barnard RJ, Heber D, Aronson WJ (2001). Evidence of an inhibitory effect of diet and exercise on prostate cancer cell growth. J Urol 166, 1185-1189.
28. US Cancer Statistics Working Group (2003). United States Cancer Statistics: 2000 Incidence. Department of Health, Human Services, Centers for Disease Control, Prevention, National Cancer Institute, Atlanta.
29. Wang Y, Corr JG, Thaler HT, Tas Y, Fair WR, Heston WD (1995). Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst 87, 1456-1462.
30. Whittemore AS, Kolonel LN, Wu AH, John EM, Gallagher RP, Howe GR et al. (1995). Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst 87, 652-661.
31. Wynder EL, Rose DP. Cohen LA (1994). Nutrition and prostate cancer: A proposal for dietary intervention. Nutr Cancer 22, 1-10.
32. Yan L, Spitznagel EL (2005). Meta-analysis of soy food and risk of prostate cancer in men. Int J Cancer 20, 667-669.